Published: 2023 | Last reviewed: May 2026
Applications of iPSC-Derived Cells in Assays
- Key Takeaways
- iPSC-derived cells offer more physiologically relevant models compared to traditional immortalized cell lines
- Applications span drug screening, toxicity testing, and disease modeling
- Different cell types can be generated from the same donor, enabling multi-organ studies
- iPSC technology allows for patient-specific disease modeling and personalized medicine approaches
- Quality control and standardization are crucial for reproducible results
Superior Physiological Relevance: iPSC-Derived Models vs Traditional Cell Lines
While traditional immortalized cell lines like HeLa cells have been invaluable in research, iPSC-derived cells provide significantly enhanced physiological relevance. Unlike conventional cell lines that may have adapted to laboratory conditions over decades of passaging, iPSC-derived cells maintain many characteristics of their in vivo counterparts. This is particularly crucial when studying complex cellular responses, drug interactions, and disease mechanisms. For example, iPSC-derived cardiomyocytes demonstrate more natural electrophysiological properties compared to immortalized cardiac cell lines like H9c2 cells. Similarly, iPSC-derived neurons exhibit more authentic neurotransmitter responses than commonly used neuroblastoma lines such as SH-SY5Y cells. This enhanced physiological relevance translates to more predictive in vitro assays and more reliable research outcomes.